SI1968990T1 - Vodotopna benzoazepiska spojina in njen farmacevtski sestavek - Google Patents

Vodotopna benzoazepiska spojina in njen farmacevtski sestavek

Info

Publication number: SI1968990T1
Authority: SI; Slovenia
Prior art keywords: soluble; water; pharmaceutical composition; benzoazepine compound; benzoazepine
Prior art date: 2005-12-27

Application number

SI200631915T

Other languages

English (en)

Inventor

Makoto Komatsu

Fumitaka Goto

Yasuhiro Menjo

Keigo Yamada

Takakuni Matsuda

Yusuke Kato

Original Assignee

Otsuka Pharmaceutical Co., Ltd.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-12-27

Filing date

2006-12-22

Publication date

2015-05-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37877008&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1968990(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2006-12-22 Application filed by Otsuka Pharmaceutical Co., Ltd. filed Critical Otsuka Pharmaceutical Co., Ltd.

2015-05-29 Publication of SI1968990T1 publication Critical patent/SI1968990T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
- C07F9/5535—Seven-(or more) membered rings condensed with carbocyclic rings or ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Hematology (AREA)
Epidemiology (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

SI200631915T 2005-12-27 2006-12-22 Vodotopna benzoazepiska spojina in njen farmacevtski sestavek SI1968990T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2005375457		2005-12-27
EP06843686.4A EP1968990B1 (en)	2005-12-27	2006-12-22	Water-soluble benzoazepine compound and its pharmaceutical composition
PCT/JP2006/326311 WO2007074915A1 (en)	2005-12-27	2006-12-22	Water-soluble benzoazepine compound and its pharmaceutical composition

Publications (1)

Publication Number	Publication Date
SI1968990T1 true SI1968990T1 (sl)	2015-05-29

Family

ID=37877008

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200631915T SI1968990T1 (sl)	2005-12-27	2006-12-22	Vodotopna benzoazepiska spojina in njen farmacevtski sestavek

Country Status (23)

Country	Link
US (6)	US20100004206A1 (sl)
EP (2)	EP2674436A1 (sl)
JP (2)	JP4644287B2 (sl)
KR (1)	KR101008931B1 (sl)
CN (1)	CN101346390B (sl)
AR (2)	AR058737A1 (sl)
AU (1)	AU2006330277B2 (sl)
BR (1)	BRPI0620715A2 (sl)
CA (1)	CA2633929A1 (sl)
CY (1)	CY1116208T1 (sl)
DK (1)	DK1968990T3 (sl)
ES (1)	ES2533007T3 (sl)
HK (1)	HK1121461A1 (sl)
IL (1)	IL191935A (sl)
MY (1)	MY146042A (sl)
NO (1)	NO342436B1 (sl)
PL (1)	PL1968990T3 (sl)
PT (1)	PT1968990E (sl)
RU (1)	RU2418804C2 (sl)
SI (1)	SI1968990T1 (sl)
TW (1)	TWI323257B (sl)
WO (1)	WO2007074915A1 (sl)
ZA (1)	ZA200805011B (sl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI459947B (zh)	2007-06-26	2014-11-11	Otsuka Pharma Co Ltd	苯并氮呯化合物及藥學製劑
JP5590780B2 (ja) *	2007-06-26	2014-09-17	大塚製薬株式会社	医薬
WO2009149493A1 (en) *	2008-06-09	2009-12-17	Dimerix Bioscience Pty Ltd	Novel receptor hetero-dimers/-oligomers
CN102020609A (zh) *	2009-09-17	2011-04-20	北京本草天源药物研究院	托伐普坦晶体或无定形物及其制备方法
DE102010041263A1 (de) *	2010-09-23	2012-03-29	Siemens Medical Instruments Pte. Ltd.	Hörgerätegehäuse mit Dichtungslippe
TWI633887B (zh) *	2012-05-31	2018-09-01	大塚製藥股份有限公司	用於預防及／或治療多囊性腎臟病之藥物
AU2013366872A1 (en) *	2012-12-28	2015-07-02	Otsuka Pharmaceutical Co., Ltd.	Injectable depot formulation comprising optically active tolvaptan and process of producing the same
TW201605488A (zh)	2013-10-15	2016-02-16	大塚製藥股份有限公司	用以預防及／或治療多囊腎病之藥物
CN109476686B (zh) *	2016-07-07	2022-01-18	赛克里翁治疗有限公司	sGC刺激剂的磷前药
JP2021014406A (ja) *	2017-10-25	2021-02-12	トーアエイヨー株式会社	バソプレシン受容体拮抗剤
JP7176104B2 (ja) *	2019-01-30	2022-11-21	大塚製薬株式会社	ベンゾアゼピン化合物の製造方法
KR20210144810A (ko)	2019-03-28	2021-11-30	오츠카 세이야쿠 가부시키가이샤	벤조아제핀 화합물-함유 동결건조 조성물
JP7130879B2 (ja) *	2019-03-28	2022-09-05	大塚製薬株式会社	ベンゾアゼピン化合物含有医薬組成物
CA3207957A1 (en)	2021-02-10	2022-08-18	Shanghai Senhui Medicine Co., Ltd.	Benzazepine compounds, preparation method therefor and pharmaceutical use thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5043273A (en)	1989-08-17	1991-08-27	Monsanto Company	Phosphorylated glycosidase inhibitor prodrugs
US5753677A (en) *	1989-10-20	1998-05-19	Otsuka Pharmaceutical Co., Ltd.	Benzoheterocyclic compounds
US5258510A (en)	1989-10-20	1993-11-02	Otsuka Pharma Co Ltd	Benzoheterocyclic compounds
CA2066104C (en)	1991-04-19	2003-05-27	Hidenori Ogawa	Benzazepine derivatives as vasopressin antagonists
US5466683A (en) *	1994-08-25	1995-11-14	Teva Pharmaceutical Industries Ltd.	Water-soluble analogs of carbamazepine
GB9602080D0 (en)	1996-02-02	1996-04-03	Pfizer Ltd	Pharmaceutical compounds
JP4210355B2 (ja)	1997-07-03	2009-01-14	大塚製薬株式会社	固形製剤組成物
US5972882A (en) *	1997-12-15	1999-10-26	University Of Kansas Medical Center	Treatment of polycystic kidney disease using vasopressin V2 receptor antagonists
US6436989B1 (en) *	1997-12-24	2002-08-20	Vertex Pharmaceuticals, Incorporated	Prodrugs of aspartyl protease inhibitors
TWI322689B (en)	2003-02-24	2010-04-01	Otsuka Pharma Co Ltd	Method for treating severe heart failure and medicament therefor

2006
- 2006-12-22 MY MYPI20082112A patent/MY146042A/en unknown
- 2006-12-22 CA CA002633929A patent/CA2633929A1/en not_active Abandoned
- 2006-12-22 ES ES06843686.4T patent/ES2533007T3/es active Active
- 2006-12-22 PL PL06843686T patent/PL1968990T3/pl unknown
- 2006-12-22 SI SI200631915T patent/SI1968990T1/sl unknown
- 2006-12-22 PT PT68436864T patent/PT1968990E/pt unknown
- 2006-12-22 JP JP2008530267A patent/JP4644287B2/ja active Active
- 2006-12-22 EP EP13183898.9A patent/EP2674436A1/en not_active Withdrawn
- 2006-12-22 RU RU2008130887/04A patent/RU2418804C2/ru active
- 2006-12-22 BR BRPI0620715-4A patent/BRPI0620715A2/pt not_active Application Discontinuation
- 2006-12-22 KR KR1020087018000A patent/KR101008931B1/ko active IP Right Grant
- 2006-12-22 DK DK06843686T patent/DK1968990T3/da active
- 2006-12-22 EP EP06843686.4A patent/EP1968990B1/en not_active Not-in-force
- 2006-12-22 ZA ZA200805011A patent/ZA200805011B/xx unknown
- 2006-12-22 WO PCT/JP2006/326311 patent/WO2007074915A1/en active Application Filing
- 2006-12-22 AU AU2006330277A patent/AU2006330277B2/en not_active Ceased
- 2006-12-22 US US12/159,027 patent/US20100004206A1/en not_active Abandoned
- 2006-12-22 CN CN2006800494221A patent/CN101346390B/zh active Active
- 2006-12-25 TW TW095148734A patent/TWI323257B/zh not_active IP Right Cessation
- 2006-12-26 AR ARP060105779A patent/AR058737A1/es not_active Application Discontinuation
2008
- 2008-06-04 IL IL191935A patent/IL191935A/en not_active IP Right Cessation
- 2008-06-05 NO NO20082630A patent/NO342436B1/no not_active IP Right Cessation
2009
- 2009-02-25 HK HK09101802.7A patent/HK1121461A1/xx not_active IP Right Cessation
2010
- 2010-10-22 JP JP2010237235A patent/JP5550522B2/ja not_active Expired - Fee Related
- 2010-12-13 US US12/966,629 patent/US20110082110A1/en not_active Abandoned
- 2010-12-28 US US12/980,266 patent/US20110098250A1/en not_active Abandoned
2012
- 2012-05-01 US US13/461,665 patent/US20120277189A1/en not_active Abandoned
- 2012-05-01 US US13/461,642 patent/US9809609B2/en not_active Expired - Fee Related
2013
- 2013-08-12 US US13/964,853 patent/US9303052B2/en not_active Expired - Fee Related
2015
- 2015-04-27 CY CY20151100385T patent/CY1116208T1/el unknown
2016
- 2016-12-26 AR ARP160104016A patent/AR107193A2/es unknown

Also Published As

Publication number	Publication date
ES2533007T3 (es)	2015-04-06
HK1121461A1 (en)	2009-04-24
US20120277188A1 (en)	2012-11-01
IL191935A0 (en)	2008-12-29
NO20082630L (no)	2008-09-16
US20110098250A1 (en)	2011-04-28
US20100004206A1 (en)	2010-01-07
RU2418804C2 (ru)	2011-05-20
JP2009521397A (ja)	2009-06-04
CN101346390B (zh)	2011-11-09
KR101008931B1 (ko)	2011-01-17
EP1968990B1 (en)	2015-02-11
WO2007074915A8 (en)	2007-11-08
TWI323257B (en)	2010-04-11
CN101346390A (zh)	2009-01-14
NO342436B1 (no)	2018-05-22
CA2633929A1 (en)	2007-07-05
US9809609B2 (en)	2017-11-07
AU2006330277B2 (en)	2011-10-06
US9303052B2 (en)	2016-04-05
EP1968990A1 (en)	2008-09-17
KR20080078916A (ko)	2008-08-28
IL191935A (en)	2013-07-31
EP2674436A1 (en)	2013-12-18
TW200734309A (en)	2007-09-16
AR107193A2 (es)	2018-03-28
US20120277189A1 (en)	2012-11-01
US20110082110A1 (en)	2011-04-07
AU2006330277A1 (en)	2007-07-05
JP5550522B2 (ja)	2014-07-16
PT1968990E (pt)	2015-03-16
AR058737A1 (es)	2008-02-20
JP4644287B2 (ja)	2011-03-02
JP2011046731A (ja)	2011-03-10
WO2007074915A1 (en)	2007-07-05
BRPI0620715A2 (pt)	2011-11-22
PL1968990T3 (pl)	2015-06-30
US20130331358A1 (en)	2013-12-12
MY146042A (en)	2012-06-15
RU2008130887A (ru)	2010-02-10
CY1116208T1 (el)	2017-02-08
DK1968990T3 (da)	2015-04-27
ZA200805011B (en)	2009-11-25

Publication	Publication Date	Title
IL191935A0 (en)	2008-12-29	Water-soluble benzoazepine compound and its pharmaceutical composition
IL190292A (en)	2017-01-31	History of pyridopyrimidinone and their pharmaceutical preparations
EP1857489A4 (en)	2010-06-23	MICROPARTICLE AND PHARMACEUTICAL COMPOSITION
HK1121162A1 (en)	2009-04-17	Oxazole compound and pharmaceutical composition
IL188941A0 (en)	2008-04-13	Pyrazinolyguanidine derivatives and pharmaceutical compositions containing the same
IL186738A0 (en)	2008-02-09	Pyrizole derivatives and pharmaceutical compositions containing the same
EP1890677A4 (en)	2013-01-30	PHARMACEUTICAL COMPOSITIONS AND THEIR USE
IL183919A0 (en)	2007-10-31	Triazolophthalazine derivatives and pharmaceutical compositions containing the same
IL189782A0 (en)	2008-08-07	Sulphonylpyrrole derivatives and pharmaceutical compositions containing the same
IL186336A0 (en)	2008-01-20	Pharmaceutical composition
IL183986A0 (en)	2007-10-31	Pharmaceutical compounds and compositions
ZA200803283B (en)	2009-11-25	Pharmaceutical gallium compositions and methods
IL184996A0 (en)	2007-12-03	Dihydroimidazothiazole derivatives and pharmaceutical compositions containing the same
EP1937255A4 (en)	2013-06-26	PHARMACEUTICAL COMPOSITION
ME01453B (me)	2014-04-20	Čvrste farmaceutske kompozicije koje sadrže valsartan
EP2070919A4 (en)	2010-05-05	SPIROCHINONE COMPOUND AND PHARMACEUTICAL COMPOSITION
EP1862184A4 (en)	2012-12-19	PHARMACEUTICAL COMPOSITION
IL189172A0 (en)	2008-06-05	Cercosporamide derivatives and pharmaceutical compositions containing the same
ZA200705131B (en)	2008-06-25	Solid pharmaceutical composition comprising valsartan
ZA200709692B (en)	2008-11-26	Antineoplastic compounds and pharmaceutical compositions thereof
IL186337A0 (en)	2008-01-20	Stannsoporfin compositions and administration
IL188011A0 (en)	2008-03-20	Spiro-benzimidazole derivatives and pharmaceutical compositions containing the same
EP1937292A4 (en)	2010-02-03	LOPAP-BASED PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
IL189827A0 (en)	2008-11-03	Pharmaceutical dosage forms and compositions comprising lecoztan
EP1865777A4 (en)	2008-07-16	STANNSOPORFIN COMPOSITIONS AND ADMINISTRATION